Skip to main content

GENERAL COMMENTARY article

Front. Immunol., 18 August 2014
Sec. T Cell Biology
Volume 5 - 2014 | https://doi.org/10.3389/fimmu.2014.00401
This article is part of the Research Topic Investigating and harnessing T-cell functions with engineered immune receptors and their ligands. View all 21 articles

Expression of concern: Co-receptor CD8-mediated modulation of T-cell receptor functional sensitivity and epitope recognition degeneracy

This article is a commentary on:

  1. Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy

    1. Read original article
Frontiers in Immunology Editorial Office* Frontiers in Immunology Editorial Office*
  • Frontiers in Immunology Editorial Office, Frontiers, Lausanne, Switzerland

Co-receptor CD8-mediated modulation of T-cell receptor functional sensitivity and epitope recognition degeneracy
by Szomolay B, Williams T, Wooldridge L and van den Berg HA. Front Immunol (2013) 4:329. doi:10.3389/fimmu.2013.00329

Expression of Concern

The Editorial Board has been informed by the authors of “Co-receptor CD8-mediated modulation of T-cell receptor functional sensitivity and epitope recognition degeneracy” that the parameter values as reported in the legends are mutually inconsistent and therefore the results of the simulations have to be reconfirmed. This is to notify readers that the data as published in the original article are not validated and that the authors have stated to the Editorial Board that a Corrigendum is in preparation.

UPDATE: This article has now been corrected. Please find the full correction here: https://doi.org/10.3389/fimmu.2014.00443

Citation: Frontiers in Immunology Editorial Office (2014) Expression of concern: Co-receptor CD8-mediated modulation of T-cell receptor functional sensitivity and epitope recognition degeneracy. Front. Immunol. 5:401. doi: 10.3389/fimmu.2014.00401

Received: 06 August 2014; Accepted: 06 August 2014;
Published online: 18 August 2014.

Copyright: © 2014 Frontiers in Immunology Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: immunology.editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.